baber/WOPTO huggingface dataset:
Patent CA-3035380-A1 (CA)
Title: Bathroom vanity with retractable step
Inventor: COOPER JOHN DAVID
IPC: A47B46/00
Filed: 2019-02-28
Abstract: A bathroom vanity with a retractable step is disclosed herein. The bathroom vanity includes a cabinet body portion including a top wall and a plurality of sidewalls, and defining a bottom recess with an open bottom; and a retractable step slidingly coupled to the cabinet body portion and being displaceable between a stowed position where the retractable step is disposed within the bottom recess of the cabinet body portion and an extended position where the retractable step extends outwardly from a front of the cabinet body portion so as to provide a step for a user of the bathroom vanity, the retractable step being configured to slide along a floor on which the bathroom vanity is disposed when the retractable step is displaced, and at least a portion of the retractable step being configured to contact the floor when the retractable step is displaced.
Patent CA-3035381-A1 (CA)
Inventor: BRUUN HEIDI ZIEGLER
IPC: A61K31/352
Filed: 2019-03-01
Abstract: La présente invention concerne une composition de gomme à mâcher en comprimés destinée à une administration orale de cannabinoïdes, la composition comprenant des ingrédients de gomme à mâcher hydrosolubles et une base de gomme insoluble dans leau qui se trouvent dans plusieurs particules et dans laquelle la composition de gomme à mâcher comprend un ou plusieurs cannabinoïdes et comporte un taux de libération du ou des cannabinoïdes supérieure à 20 % en poids du ou des cannabinoïdes dans les cinq premières minutes lors de ladministration orale.
Patent CA-3035947-A1 (CA)
Title: Method and measurement apparatus for measuring suspension
Inventor: KARKI PASI
IPC: G01N15/06
Filed: 2019-03-05
Abstract: The invention relates to method of measuring a suspension which contains wood fibres. The consistency of the suspension is changed (100) in a consistency range. Optical radiation using a first optical wavelength and a second optical wavelength is directed (102) at the suspension. A first intensity value of the optical radiation related to the first optical wavelength and a second intensity value related to the second optical wavelength on at least one given consistency value is determined (104). The ratio of the first and second intensity values is determined (106). Kappa number of the suspension is determined (108). A raw value for hexenuronic acid, HexA is obtained (110) by applying predetermined factors to the ratio of the first and second intensity values. The content of HexA in the suspension is determined (112) by multiplying the determined ratio with the kappa number.
Patent CA-3037823-A1 (CA)
Inventor: SHADFORTH IAN
IPC: A61B5/00
Filed: 2017-09-21
Abstract: L'invention concerne des procédés et des systèmes donnés à titre d'exemple qui facilitent la présentation de données dérivées de mesures du cur dans une intervention non effractive (par exemple par analyse de tomographie d'espace de phase). En particulier, les procédés et systèmes donnés à titre d'exemple facilitent la présentation de telles mesures dans une interface utilisateur graphique, ou « GUI » (par exemple, associée à un portail Web de fournisseur de soins de santé destiné à être utilisé par des médecins, des chercheurs ou des patients, etc.) et/ou dans un rapport pour le diagnostic de pathologies et de maladies cardiaques. La présentation facilite une visualisation unifiée et intuitive qui comprend des visualisations tridimensionnelles et des visualisations bidimensionnelles qui sont présentées en même temps dans une seule interface interactive et/ou un seul rapport.
Patent CA-3038153-A1 (CA)
Inventor: WANG JIN JEAN
IPC: A61K38/00
Filed: 2018-05-08
Abstract: Provided herein is a pharmaceutical composition comprising two or more compounds, wherein each compound is independently a phosphodiesterase inhibitor, an adenosine receptor antagonist, a calcium channel blocker, a histamine H1-receptor agonist, a histamine H2 -receptor agonist, a histamine H3-receptor antagonist, or a ß2-adrenoreceptor agonist. Also provided herein is a method of treating, preventing, or ameliorating a cardiovascular disease in a subject, comprising administering to the subject in need thereof two or more compounds, wherein each compound is independently a phosphodiesterase inhibitor, an adenosine receptor antagonist, a calcium channel blocker, a histamine H1- receptor agonist, a histamine H2-receptor agonist, a histamine H3-receptor antagonist, or a ß2-adrenoreceptor agonist.
Patent CA-3040022-A1 (CA)
Title: Heart valve prosthesis anchored to interventricular septum and conveying and releasing method thereof
Inventor: LV SHIWEN
IPC: A61F2/24
Filed: 2017-10-23
Abstract: The invention relates to a heart valve prosthesis (100,200,300,400,500) fixed through an interventricular septum (183,383). The heart valve prosthesis (100,200,300,400,500) comprises a valve support (110,210,310) and a fixing device (113,213,313,518). The valve support (110,210,310) comprises a valve sewing section (112,212,312,412,512) and an artificial valve (120, 520), and the artificial valve (120, 520) is fixedly connected on the valve sewing section (112,212,312,412,512); the fixing device (113,213,313,518) comprises a fixing supporting section (114,214,314, 514) and a fixing piece (115,215,315,415,515), one end of the fixing supporting section (114,214,314, 514) is connected on the end-close part of the valve sewing section (112,212,312,412,512), and the other end of the fixing supporting section (114,214,314, 514) is connected on the interventricular septum (183,383) of a patient through the fixing piece (115,215,315,415,515), supports the heart valve prosthesis (100,200,300,400,500), and limits the heart valve prosthesis (100,200,300,400,500) to axially move.
Patent CA-3041072-A1 (CA)
Title: Construction de bande coupe-feu intumescente
Inventor: HULTEEN JOHN C
IPC: A62C3/00
Filed: 2017-10-06
Abstract: La présente invention concerne un article adhésif pour la protection contre le feu, ainsi que des procédés d'utilisation de celui-ci. L'article adhésif comprend un substrat ayant une première surface principale ; un matériau intumescent lié de manière fixe à une partie centrale de la première surface principale ; et une couche adhésive disposée au moins le long de deux parties distales opposées de la première surface principale.
Patent CA-3041854-A1 (CA)
Inventor: MIYAMOTO HIDETOSHI
IPC: A61P9/10
Filed: 2017-11-27
Abstract: Provided is a crystal of a novel pyrido[3, 4-d]pyrimidine derivative having excellent CDK 4/6 inhibitory activity. A crystal of a compound represented by formula (I). In the formula, R1 represents a hydrogen atom or a C1-3 alkyl group; R2 represents a hydrogen atom or an oxo group; L represents a single bond or a C1-3 alkylene group; and X represents CH or N.
Patent CA-3042333-A1 (CA)
Inventor: KARGENIAN JOHN H
IPC: B25C5/16
Filed: 2019-05-06
Abstract: Electrically powered fastening devices configured to drive staples suited to multiple applications. The fastening device includes an adjustable feeder and depth gauge, a hammer device with a mechanism for translating rotary power to linear striking force, and a staple guide configured to drive staples with selected, specialized profiles and configured with inner radii sized and shaped to conform to particular wire and sheathing diameters.
Patent CA-3042841-A1 (CA)
Inventor: NASR MALEK
IPC: A61F2/24
Filed: 2017-11-06
Abstract: La présente invention concerne un système de valvule cardiaque, le système comprenant un corps tubulaire auto-expansible radialement, une valvule et un tissu tubulaire. Le corps tubulaire comporte une extrémité d'entrée et une extrémité de sortie. La valvule est couplée au corps tubulaire et comprend une pluralité de feuillets de valvule. Le tissu est placé sur une surface externe du corps tubulaire, et le tissu comporte une extrémité d'entrée et une extrémité de sortie. En outre, l'extrémité de sortie du tissu est directement reliée à un bord circonférentiel externe de la valvule.
Patent CA-3045175-A1 (CA)
Title: Ailette pour fleche de tir a l`arc
Inventor: POTTER ROBERT
IPC: F42B6/06
Filed: 2019-06-04
Abstract: Il est décrit une aube pour un projectile comme une flèche de tir à larc comprenant une bande de ruban ayant un bord de ruban avant qui est torsadé pour induire une rotation du projectile pendant son vol. Lailette peut comprendre une base qui monte sur une surface de projectile. La bande de ruban peut sétendre vers le haut à partir de la base et peut être semi-rigide, mais souple. La bande de ruban peut comprendre une partie intermédiaire espacée à une distance de la surface de projectile et non fixée à celle-ci afin de former un espace sous la partie intermédiaire. La bande de ruban peut comprendre une seconde extrémité de ruban fixée à la base à larrière de la première extrémité. Elle peut également comprendre une ailette qui sétend vers le haut à partir de la base dans un espace entre la bande de ruban et la base. La bande de ruban peut en variante comprendre une seconde extrémité de ruban en porte-à-faux sans fixation à la base et au projectile.
Patent CA-3045991-A1 (CA)
Title: Imaging agents and methods of use
Inventor: AWASTHI VIBHUDUTTA
IPC: A61K31/4155
Filed: 2017-11-30
Abstract: An imaging agent and a method of its use for imaging a necrosis in a tissue of a subject. The imaging method may be positron emission tomography (PET). In at least one embodiment the imaging agent comprises 2-deoxy-2-[18F]fluoroglucaric acid (18F-FGA), or a pharmaceutically-acceptable salt thereof. The imaging agent may be disposed in a pharmaceutically-acceptable excipient, carrier, diluent, or vehicle. The imaging agent may be contained within a kit. The disclosure includes in at least one embodiment a method of preparing a radiopharmaceutical such as 18F-FGA for use in imaging.
Patent CA-3047350-A1 (CA)
Title: Lentivirus and non-integrating lentivirus as viral vector to deliver crispr therapeutic
Inventor: MALCOLM THOMAS
IPC: C12N9/22
Filed: 2018-01-17
Abstract: A composition for treating a lysogenic virus, including a lentiviral vector encoding isolated nucleic acid encoding two or more gene editors chosen from gene editors that target viral DNA, gene editors that target viral RNA, and combinations thereof. A composition for treating a lytic virus, including a lentiviral vector encoding isolated nucleic acid encoding at least one gene editor that targets viral DNA and a viral RNA targeting composition. A composition for treating both lysogenic and lytic viruses, including a lentiviral vector encoding isolated nucleic acid encoding two or more gene editors that target viral RNA. A composition for treating lytic viruses. Methods of treating a lysogenic virus or a lytic virus, by administering the above compositions to an individual having a virus and inactivating the virus.
Patent CA-3047636-A1 (CA)
Title: Method and apparatus for spinal interbody fusion including fixation or locking plate
Inventor: VESTGAARDEN TOV INGE
IPC: A61F2/44
Filed: 2012-09-20
Abstract: A spinal fusion implant has a parallelepiped main body with a rotatably mounted retention plate secured to its distal end. The distal retention plate has a first position co-planar with the main body and a second, deployed position normal to the plane of the main body. The distal retention plate is in the first position when the main body is inserted between adjacent vertebral bodies and is in the second position after the main body is inserted between adjacent vertebral bodies. In further embodiments, a proximal retention plate is permanently deployed in normal relation to the main body or both the distal and proximal retention plates are rotatably mounted and both are deployed co-planar to the main body before insertion and normal to the main body after insertion.
Patent CA-3049649-A1 (CA)
Inventor: OLAUSSON LARS
IPC: D21C11/10
Filed: 2018-02-01
Abstract: The invention relates to a heat transfer tube (9) for falling film evaporation having a heating medium surface(21) to be heated by a heating medium,a falling film surface (20) to have spent liquor passing over it, and being made from an iron based high alloy stainless steel material with an alloy content above 16.00% for Chromium and above 1% for Nickel. The falling film surface of the heat transfer tube is equipped with at least one weld ridge (WR; WR1, WR2), said weld ridge having a height (h; h2 ) in the range 0.3 to 5.0mm, a width (w; w2) in the range 0.5-15 mm,and an inclination angle (a; a1, a2) versus a plane orthogonal to a longitudinal axis (CC) of the heat transfer tube in a range of 0-70 degrees so that each weld ridge is inclined and extends helically along at least a portion of the heat transfer tube or extend within a plane orthogonal to the longitudinal axis of the heat transfer tube and forms well ridge portions on the falling film surface such that the distance along the longitudinal axis of the heat transfer tube between adjacent weld ridge portions is within the range of 0 to 250 mm. The invention also relates to a method for manufacturing said heat transfer tube.
Patent CA-3050854-A1 (CA)
Title: Enhanced stability of urease inhibitor-containing compositions
Inventor: BARR DOUGLAS
IPC: C05G3/90
Filed: 2018-01-17
Abstract: Methods for enhancing the stability of urease inhibitors and urease inhibitor-containing compositions and for reducing the rate of degradation of urease inhibitors and urease inhibitor- containing compositions are provided. Such methods generally involve providing the urease inhibitor in the form of one or more adducts of the urease inhibitor with urea, an aldehyde, or both urea and the aldehyde.
Patent CA-3052466-A1 (CA)
Inventor: MARKOWITZ SANFORD D
IPC: C07D495/04
Filed: 2018-02-06
Abstract: La présente invention concerne des composés et des méthodes pour assurer la modulation de l'activité de la 15-PGDH, la modulation des taux de prostaglandine dans les tissus, le traitement de maladies, le traitement d'un état pathologique ou de troubles dans lesquels il est souhaitable de moduler l'activité de la 15-PGDH et/ou les taux de prostaglandine. Lesdits composés comprennent des inhibiteurs de la 15-PGDH selon la présente invention.
Patent CA-3052909-A1 (CA)
Inventor: WONG CHI-HUEY
IPC: C12N9/10
Filed: 2013-08-20
Abstract: A novel UDP-Gal regeneration process and its combined use with a galactosyltransferease to add galactose to a suitable acceptor substrate. Also described herein are synthetic methods for generating Globo-series oligosaccharides in large scale, wherein the methods may involve the combination of a glycosyltransferase reaction and a nucleotide sugar regeneration process.
Patent CA-3054588-A1 (CA)
Inventor: BENSOUSSAN DANIELE
IPC: A61P31/00
Filed: 2018-02-28
Abstract: The invention relates to human mesenchymal stem cells obtained from Wharton's jelly, a process for the preparation thereof, and the therapeutic uses thereof, in particular for the treatment of sepsis.
Patent CA-3054684-A1 (CA)
Title: Resonateur irm a double syntonisation, assemblage de bobines et procede
Inventor: JONES RANDALL W
IPC: G01R33/36
Filed: 2018-03-01
Abstract: La présente invention concerne un système d'assemblage de bobines à double fréquence conçu pour convertir un système IRM mononucléaire en système multinucléaire pouvant émettre et recevoir des fréquences d'au moins deux noyaux distincts, ledit système comprenant un convertisseur de fréquence couplé au système IRM pour recevoir une première fréquence par le port de bobine d'émission locale et convertir la première fréquence en une seconde fréquence, une seconde bobine d'émission de fréquence pour recevoir la seconde fréquence du convertisseur de fréquence et pour émettre la seconde fréquence, une bobine de réception à double syntonisation pour recevoir et émettre les deux fréquences ou plus, et un récepteur commutable pour recevoir les deux fréquences ou plus délivrées par la bobine de réception à double syntonisation et pour émettre la première fréquence reçue de la bobine de réception à double syntonisation directement au système IRM, et pour convertir la seconde fréquence reçue de la bobine de réception à double syntonisation en première fréquence avant l'émission vers le système IRM.
Patent CA-3055851-A1 (CA)
Title: Aircraft anti-spin systems
Inventor: NASLUND BRIAN BRENT
IPC: G05D1/10
Filed: 2019-09-17
Abstract: An anti-spin system for an aircraft can include an anti-spin module configured to execute a computer implemented method. The method can include receiving flight data from one or more aircraft flight data systems, determining if the aircraft is near stall or in a stall using the flight data, and determining if the aircraft is in uncoordinated flight while near stall or in a stall to determine if the aircraft is near spin or in a spin using the flight data.  If the aircraft is determined to be near spin, the method includes at least one of sending an alert to a warning indicator in a cockpit to warn the pilot of a spin or near spin condition, or sending a signal to an automated control system for inputting automatic control to the aircraft to avoid a spin by coordinating the aircraft or avoiding a stall while uncoordinated.
Patent CA-3057087-A1 (CA)
Title: Compounds and methods for the treatment of parasitic diseases
Inventor: COMER EAMON
IPC: A61K31/395
Filed: 2018-03-20
Abstract: Provided herein are compounds useful for the treatment of various parasitic diseases. These compounds, as well as pharmaceutically acceptable salts thereof may be formulated in pharmaceutical compostions, veterinary compositions and may be used in methods of treatment and/or prophylaxis of diseases spread by parasites, including malaria and cryptosporidiosis.
Patent CA-3057225-A1 (CA)
Title: Source d'aerosol pour systeme de production de vapeur
Inventor: Simpson Alex
IPC: A24F40/44
Filed: 2018-03-21
Abstract: L'invention concerne une source d'aérosol pour un système électronique de production de vapeur comprenant un élément chauffant (450) ; une chambre d'atomisation (465) ; un réservoir (270) destiné à contenir un liquide source à écoulement libre ; et une mèche poreuse (500) s'étendant de la chambre d'atomisation au réservoir et comprenant une partie de chauffage en coopération avec l'élément chauffant à l'intérieur de la chambre d'atomisation et au moins une partie de collecte de liquide à l'intérieur du réservoir, la partie de collecte de liquide ayant un paramètre de section transversale maximal qui est supérieur à un paramètre de section transversale équivalent de la partie de chauffage.
Patent CA-3059224-A1 (CA)
Title: Variable thickness preform for a bottle, mould and method
Inventor: THIBODEAU JAMES ALFRED
IPC: B29B11/08
Filed: 2018-04-04
Abstract: A preform (110, 210, 310, 410, 510, 610) for a container (150) has a hollow cylindrical main body (113, 213, 313, 413, 513, 613) having a first thickness, a hollow cylindrical thick portion (117, 217, 317, 417, 517, 617) having a second thickness greater than the first thickness, and a curved end portion (119, 219, 319, 419, 519, 619). Inner surfaces of the main body (113, 213, 313, 413, 513, 613), the thick portion (117, 217, 317, 417, 517, 617), and the end portion (119, 219, 319, 419, 519, 619) form a cavity (114, 214, 314, 414, 514, 614). A preform (110, 210, 310, 410, 510, 610) for a container (150) has a hollow cylindrical main body (113, 213, 313, 413, 513, 613) having a first thickness, a hollow cylindrical thick portion (117, 217, 317, 417, 517, 617) having a second thickness greater than the first thickness, and a curved end portion (119, 219, 319, 419, 519, 619). Inner surfaces of the main body (113, 213, 313, 413, 513, 613), the thick portion (117, 217, 317, 417, 517, 617), and the end portion (119, 219, 319, 419, 519, 619) form a cavity (114, 214, 314, 414, 514, 614).
Patent CA-3060569-A1 (CA)
Inventor: BOUCHER THOMAS
IPC: G16B40/00
Filed: 2018-04-19
Abstract: L'invention concerne un système et des procédés pour déterminer les allèles, les néoantigènes et une composition de vaccin tels que déterminés sur la base de mutations tumorales d'un individu. L'invention concerne également des systèmes et des procédés permettant d'obtenir des données de séquençage de grande qualité à partir d'une tumeur. En outre, la présente invention concerne des systèmes et des procédés pour identifier des changements somatiques dans les données génomiques polymorphiques. L'invention concerne enfin des vaccins anticancéreux uniques.
Patent CA-3060906-A1 (CA)
Title: Apparatus that controls an adjustable height desk and detects a user's presence
Inventor: DE LA FUENTE SANCHEZ ALFONSO F
IPC: A47B13/00
Filed: 2019-11-05
Abstract: An apparatus that control and adjustable height desk, comprising sensors that are adjustable to better cover the desired area where the user will be positioned when using the sit and stand desk. Wherein the sensors detect the presence of a user, wherein the sensors can be manually or mechanically controlled. In a different embodiment of the invention, the sensors also detect variations on the energy use from a built in power distribution hub to facilitate a determination of the presence of a user at the desk.
Patent CA-3061316-A1 (CA)
Inventor: ALLETTO EUGENE
IPC: A47G9/02
Filed: 2018-04-24
Abstract: A pillowcase (22) includes a top panel (28) and an opposite bottom panel (30). The top panel (28) has three sides that are joined with three sides of the bottom panel (30) such that inner surfaces of the top and bottom panels (28, 30) that face one another define a cavity configured for disposal of a pillow. Fourth sides of the top and bottom panels (28, 30) are not joined with one another and define an opening (34) that is in communication with the cavity. A power band (26) has one end coupled to the top panel (28) and the opposite end to the bottom panel (30) and extends across the opening (34) to prevent a pillow that is positioned within the cavity from slipping out unintentionally and/or to prevent a pillow that is positioned within the cavity from shifting within the cavity.
Patent CA-3061614-A1 (CA)
Title: Methods of treating rheumatoid arthritis using rna-guided genome editing of hla gene
Inventor: FREED BRIAN
IPC: C12N15/90
Filed: 2018-04-25
Abstract: Methods of preventing or treating rheumatoid arthritis (RA) in a subject by introducing the DRB1*04:01K71E mutation that is resistant to RA. The resistant allele is introduced into the subject having or at risk of developing RA, using a HLA CRISPR/Cas9 vector that targets codon 71 in the HLA allele DRB1*04:01, introducing a single A to G point mutation in codon 71 by homology directed repair to alter the lysine at position 71 of the expressed protein to glutamic acid. This modified allele is affected in the subject's hematopoietic stem cells, which are then expanded and transplanted back into the patient. This microgene therapy confers RA-resistance via an autologous transplant. The invention includes isolated nucleic acids, vectors, recombinant viruses, cells, and pharmaceutical compositions to modify the HLA DRB1*04:01 allele.
Patent CA-3061780-A1 (CA)
Title: Devices, systems and methods for communications that include social media clients
Inventor: NAIDOO LOGENDRA
IPC: H04L12/16
Filed: 2019-11-15
Abstract: Devices, systems and methods for communications that include social media clients are provided. In particular, a server operates a virtual client for communicating with clients of a social media server. The server receives a call request associated with a directory number of a call server, the call request to initiate a call associated with the directory number and a given client of the social media server. The server conducts the call by controlling: the virtual client to communicate with the given client, via the social media server; and the virtual client to communicate with a communication device associated with the directory number, via the call server. The server may also facilitate exchange of status updates between a given client of the social media server and the call server. The server may also facilitate calls between respective clients of different social media servers.